Navigation Links
Glass Lewis Recommends Shareholders Support LCA-Vision Board of Directors and Reject All Three Proposals by Dissident Joffe Group
Date:2/27/2009

Urges LCA-Vision Stockholders to Vote GOLD

CINCINNATI, Feb. 27 /PRNewswire-FirstCall/ -- LCA-Vision Inc. (Nasdaq: LCAV) announces that Glass Lewis & Co., LLC, a leading independent research and proxy advisory firm, today recommended that LCA-Vision stockholders vote to retain the Company's current Board of Directors and reject all of the proposals, including the removal of the current Directors and election of replacement Directors, in the Joffe Group's consent solicitation.

In short, Glass Lewis recommends that LCA-Vision stockholders vote the GOLD card on all three proposals.

In its report, Glass Lewis concludes that:

  • The incumbent directors of LCA-Vision are in the best position to guide the Company during a turnaround period.
  • The current management team has articulated a plan to enhance shareholder value by: 1) preserving cash through cash and expense management; 2) enhancing marketing strategies; 3) expanding the Company's marketing presence into new domestic markets; and 4) expanding the existing business model into other complementary medical procedures and services through a new Lifetime Vision model.
  • The Joffe Group's operations plan and business strategy as presented are "particularly thin."
  • Glass Lewis cannot support the appointment of Stephen Joffe as a Director, in light of accounting discrepancies at the Company during the tenure of Joffe Group members Stephen Joffe, Craig Joffe and Alan Buckey as senior executive officers of the Company.
  • The Company, under Stephen Joffe's leadership (and while Alan Buckey was CFO), "was not effectively managing its financial reporting practices or lacked internal accounting expertise."
  • Edward VonderBrink, as chairman of the audit committee at Streamline Health Solutions, "has not performed that responsibility to the satisfaction of the Streamline shareholders."
  • The remainder of the Joffe Group's nominees do not "provide any unique or necessary experience" that would benefit the Company.
  • LCA-Vision's performance has been, on balance, in line with the Company's closest competitor.

"We are delighted that Glass Lewis has recommended that our stockholders reject all three Joffe Group proposals, as it is consistent with our belief that current management and the Board of Directors are diligently working in concert to build stockholder value," said Steven Straus, LCA-Vision chief executive officer. "We have undertaken a multi-initiative plan that encompasses all aspects of our business with the goals of transitioning to a sustainable growth model, while managing our cash. We are realizing tangible results of our plan as evidenced by our increase in market share to 11.9% in the fourth quarter of 2008 from 10.5% in the third quarter. We believe we are on the right track and urge our stockholders to vote for our current Board and management team."

Due to the nature of the Consent process, your voting instruction is extremely important and time sensitive. LCA-Vision urges all stockholders to vote their GOLD cards to REVOKE CONSENT on all three proposals. Please discard any proxy card that you receive from the Joffe Group. If you have already voted to consent and wish to change your vote, you have every right to revoke your consent and vote the GOLD proxy. Only the latest dated card counts.

LCA-Vision filed its Definitive Consent Revocation Statement ("Consent Revocation Statement") with the Securities and Exchange Commission on Monday, February 9, 2009, and copies of the Consent Revocation Statement with a GOLD Consent Revocation Card were mailed to stockholders beginning February 10, 2009. The Consent Revocation Statement can be obtained immediately from the SEC's website at the following link:

http://idea.sec.gov/Archives/edgar/data/1003130/000114420409006021/v139094_defc14a.htm

or from the Investor Relations section of the Company's website at www.lasikplus.com and www.lca-vision.com . Copies of the Consent Revocation Statement and consent revocation card may also be obtained from Georgeson Inc.

Additional Information:

Georgeson Inc. has been retained by LCA-Vision as consent revocation solicitation agent. Stockholders with questions are encouraged to call Georgeson toll-free 1-800-457-0109. Copies of the Company's Consent Revocation Statement, and any other documents filed by LCA-Vision with the SEC in connection with the consent solicitation can be obtained free of charge from the SEC's website at www.sec.gov, from the Company's website at www.lasikplus.com and www.lca-vision.com , or from Georgeson.

About LCA-Vision Inc./LasikPlus(R)

LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus(R) brand, operates 75 LasikPlus(R) fixed-site laser vision correction centers in 32 states and 57 markets in the United States and a joint venture in Canada. Additional company information is available at www.lca-vision.com and www.lasikplus.com.

                     Earning Trust Every Moment.
                                        Transforming Lives Every Day.

    For Additional Information

    Company Contact:
    Barb Kise
    LCA-Vision Inc.
    513-792-9292

    Investor Relations Contact:
    Jody Cain
    Lippert/Heilshorn & Associates
    310-691-7100


'/>"/>
SOURCE LCA-Vision Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. During Tough Economic Times Remember Your Health - Save With Your AAA Membership on Necessities From Prescriptions to Eyeglasses
2. The New Crystalens HD Gives Many Baby Boomers and Seniors an Opportunity to See Clearly at All Distances while Reducing or Eliminating the Need for Glasses
3. Hundreds of Uninsured Georgia School Children to Receive Free Eye Exams and Glasses
4. Prescription Safety Glasses Protect Employees Vision
5. Do You Need Glasses?
6. Eyeglass Dispensary and Contact Lens Now Available at Global Laser Vision
7. Video: A Toast to the Cure Set for October 30 Breast Cancer Survivors Raise Your Glasses
8. A glass apart
9. Daily Glass of Wine Cut Risk of Fatty Liver Disease
10. Kids Think Glasses Make Others Look Smart, Honest
11. Prism glasses expand the view for patients with hemianopia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are confused ... endometriosis. These women need a treatment plan to not only alleviate symptoms and ... help for preservation of fertility and ultimately achieving a pregnancy. The specialists at ...
(Date:6/25/2016)... ... 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users can easily ... of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures ... . Simply select a ProHand generator and drag it above media or text in ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary of ... award to iHire in recognition of their exemplary accomplishments in worksite health promotion. , ... Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was ...
(Date:6/24/2016)... ... , ... June 19, 2016 is World Sickle Cell Observance Day. In an ... of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a ... Cell Disease (SCD) is a disorder of the red blood cells, which can cause ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... ... is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- Guerbet announced today that it has been named a ... One of 12 suppliers to receive the ... of Premier members through exceptional local customer service and ... lower costs. "We ... customer service from Premier," says Massimo Carrara , ...
(Date:6/23/2016)... June 23, 2016 Research and ... Procedure Volumes: Global Analysis (United States, China, Japan, Brazil, ... report to their offering. ... for healthcare business planners, provides surgical procedure volume data ... trends with an in-depth analysis of growth drivers and ...
(Date:6/23/2016)... The Biotechnology industry might still ... great opportunities to investors. Stock-Callers.com assesses the recent performances ... XON ), Vertex Pharmaceuticals Inc. (NASDAQ: ... ARNA ), and Regeneron Pharmaceuticals Inc. (NASDAQ: ... your complimentary trade alerts at: http://stock-callers.com/registration ...
Breaking Medicine Technology: